{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Digoxin: \ud83c\udf0d Ancient Remedy, Modern Evidence, Global Relevance","description":"\ud83e\udec0 Old drug. New evidence. Renewed relevance. Two major JAMA studies published in 2026 revisit the role of digoxin\/digitalis glycosides in modern cardiovascular care. \ud83d\udcca A meta-analysis of 9,013 patients with HFmrEF\/HFrEF showed reduced worsening heart failure events without increased mortality. \ud83c\udf0d The Dig-RHD randomized trial from India demonstrated that digoxin reduced death or worsening heart failure in symptomatic rheumatic heart disease with minimal toxicity. Key message: \ud83d\udc8a Digoxin may still have an important role as affordable adjunctive therapy\u2014especially in resource-limited settings and carefully selected patients. Sometimes the oldest medicines still have new stories to tell. #Cardiology #HeartFailure #Digoxin #RheumaticHeartDisease #JAMA #Digitalis #HFmrEF #HFrEF #GlobalHealth #CardioTwitte ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41263450\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/201860230"}